1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HDLBP CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA EFNB2 CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA SCYL1 CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA FGF2 CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA KCNAB2 CTRPv2 pan-cancer AAC 0.15 0.0006
mRNA ASAP3 CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA FES CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA TBC1D19 CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA IRF6 CTRPv2 pan-cancer AAC 0.16 0.0006
mRNA ADH5 CTRPv2 pan-cancer AAC -0.12 0.0006
Download CSV